Yanan Shan
CIK: 0002123327
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BYAH
Park Ha Biological Technology Co., Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Shan Yanan
Shan Yanan (SEC CIK 0002123327) files insider reports with the SEC as Director of Park Ha Biological Technology Co., Ltd. (BYAH).
Signal8 holds 1 ownership filing by Shan Yanan, a Form 3, filed on Apr 7, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Shan Yanan's filings is in WUXI.
Other insiders filing for Park Ha Biological Technology Co., Ltd. (BYAH)
- Wang Li (Alya), COO
- Zhu Xiaoyan, CFO
- Li Xinyu, CTO
- Yu Xiaozhong, Director
- Zhang Xiaoqiu, CEO
- Sheng Qixiong, Director